Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 20, 2018

Primary Completion Date

February 28, 2024

Study Completion Date

May 30, 2024

Conditions
Adrenocortical Carcinoma
Interventions
DRUG

Cisplatin plus Etoposide

"Etoposide 100 mg/m2 will be administered IV on days 1, 2, 3 diluted in 500 mL of isotonic NaCl or 5% dextrose.~Cisplatin, 80 mg/m2 will be administered IV on day 1, diluted in 500 mL of isotonic NaCl."

OTHER

Observation or Mitotane

Observation or mitotane alone according to the investigator's preference

Trial Locations (1)

25123

ASST Spedali Civili di Brescia, Brescia

All Listed Sponsors
lead

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

OTHER

NCT03723941 - Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma | Biotech Hunter | Biotech Hunter